Molecular Pharmacology | Balance Sheet
Fiscal year is July-June. All values USD Thousands.
2010
2011
2012
2013
2014
Cash & Short Term Investments
8.00
8.70
2.60
7.00
2.40
Total Accounts Receivable
1.50
6.60
5.10
5.10
6.50
Total Current Assets
9.50
15.30
7.70
12.10
8.90
Net Property, Plant & Equipment
2.20
1.60
1.20
0.10
0.10
Total Assets
11.70
16.90
8.80
12.30
9.00
Accounts Payable
20.80
20.10
19.30
21.60
-
Other Current Liabilities
-
1,963.50
2,069.40
2,044.50
2,241.80
Total Current Liabilities
20.80
1,983.60
2,088.70
2,066.10
2,241.80
Other Liabilities
1,477.70
-
-
-
-
Total Liabilities
1,498.50
1,983.60
2,088.70
2,066.10
2,241.80
Common Equity (Total)
1,486.90
1,966.70
2,079.90
2,053.90
2,232.90
Total Shareholders' Equity
1,486.90
1,966.70
2,079.90
2,053.90
2,232.90
Total Equity
1,486.90
1,966.70
2,079.90
2,053.90
2,232.90
Liabilities & Shareholders' Equity
11.70
16.90
8.80
12.30
9.00
About Molecular Pharmacology
View Profile
